Main Session
Sep
28
QP 09 - Fewer Fractions, Greater Precision: Innovations in Prostate SBRT
1050 - Five-Year Outcomes from a Prospective Trial of MR-Guided SBRT with Focal DIL Boost for Intermediate-Risk Prostate Cancer
Presenter(s)
Alexander Goglia, MD, PhD - Memorial Sloan Kettering Cancer Center, New York, NY